Position in TECH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,947,464
-$1,987,501 QoQ
Shares Held
56,400
-18.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWINBEECH CAPITAL LP holds $33,258,211 across 31 Biotechnology names. TECH ranks #2 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
65,900 | $3,829,449 | |
| 2 | TECH |
BIO-TECHNE Corp
This page
|
56,400 | $2,947,464 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
90,006 | $2,102,540 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
221,841 | $1,998,787 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
56,100 | $1,825,494 | |
| 6 | MRNA |
Moderna, Inc.
|
34,668 | $1,761,134 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
50,900 | $1,512,239 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
76,884 | $1,503,851 |
All Filings in TECH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,947,464 | 56,400 | Shares | Sole | 2026-05-15 | |
| 2024-06-30 | $4,934,965 | 68,876 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,017,359 | 85,486 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $3,433,995 | 50,448 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,277,032 | 17,213 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,159,146 | 16,326 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,391,209 | 27,593 | Shares | Sole | 2022-08-15 | |
| 2020-09-30 | $170,562 | 2,754 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $105,165 | 1,593 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||